1-2 of 2
Hui Deng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma

Marina Li, Cindy Lin, Hui Deng, Joann Strnad, Luca Bernabei, Dan T. Vogl, James J. Burke, Yulia Nefedova
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (7): 1530–1538.
https://doi.org/10.1158/1535-7163.MCT-19-1020
Published: 02 July 2020
View article titled, A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma
Open the PDF for A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xuejun Fan, Randall J. Brezski, Hui Deng, Pooja M. Dhupkar, Yun Shi, Anneliese Gonzalez, Songlin Zhang, Michael Rycyzyn, William R. Strohl, Robert E. Jordan, Ningyan Zhang, Zhiqiang An
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (3): 681–691.
https://doi.org/10.1158/1535-7163.MCT-14-0715
Published: 09 March 2015
View article titled, A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies
Open the PDF for A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies in another window
Includes: Supplementary data